C21H44BNO2Si2
Neat
409.57
514820-48-5; 1, 1, 1-Trimethyl-N-((R)-3-methyl-1-((3aS, 4S, 6S, 7aR)-3a, 5, 5-trimethylhexahydro-4, 6-methanobenzo[d][1, 3, 2]dioxaborol-2-yl)butyl)-N-(trimethylsilyl)silanamine; (1R)-3-Methyl-1-[(1S, 2S, 6R, 8S)-2, 9, 9-trimethyl-3, 5-dioxa-4-boratricyclo[6.1.1.02, 6]decan-4-yl]-N, N-bis(trimethylsilyl)butan-1-amine; N, N-Bis(trimethylsilyl)-(1R)-1-[(3aS, 4S, 6S, 7aR)-hexahydro-3a, 5, 5-trimethyl-4, 6-methano-1, 3, 2-benzodioxaborol-2-yl]-3-methylbutylamine; Bortezomib Impurity 54; Bortezomib Impurity N47; SCHEMBL554519; 1, 1, 1-Trimethyl-N-{(1r)-3-Methyl-1-[(3 as, 4s, 6s, 7ar)-3a, 5, 5-Trimethylhexahydro-4, 6-Methano-1, 3 and 2-Benzodioxaborol-2-Y1]Butyl}-N-(Trimethylsilyl)Silanamine
(1R)-3-methyl-1-[(1S, 2S, 6R, 8S)-2, 9, 9-trimethyl-3, 5-dioxa-4-boratricyclo[6.1.1.02, 6]decan-4-yl]-N and N-bis(trimethylsilyl)butan-1-amine
InChI=1S/C21H44BNO2Si2/c1-15(2)12-19(23(26(6,7)8)27(9,10)11)22-24-18-14-16-13-17(20(16,3)4)21(18,5)25-22/h15-19H,12-14H2,1-11H3/t16-,17-,18+,19-,21-/m0/s1